Biomarkers in cerebrospinal fluid can identify patients with Alzheimer's disease

Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer's disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer's disease.

Due to the similarity of the symptoms, differentiating patients with Alzheimer's from those with other types of dementia – or patients with Parkinsondisease from those with other motor disorders – is often difficult.

Making a proper diagnosis is essential if proper treatment and medication are to commence at an early stage. A research team at Sahlgrenska Academy, University of Gothenburg, is developing a new method to differentiate patients with Alzheimer's disease or Parkinson disease by analyzing a sample.

The study, led by Professor Kaj Blennow and conducted among 450 patients at Skåne University Hospital and Sahlgrenska University Hospital, involved testing five proteins that serve as biomarkers for the two diseases.

"Previous studies have shown that Alzheimer's disease is associated with in specific proteins of the brain," says Annika Öhrfelt, a researcher at Sahlgrenska Academy. "This study has found that the inclusion of a new protein can differentiate patients with Alzheimer's disease from those with Lewy body dementia, Parkinson disease dementia and other types of ."

Similarly, the biomarkers can differentiate patients with from those with atypical Parkinsonian disorders.

"Additional studies are needed before the can be used in clinical practice during the early stages of disease," says Öhrfelt, "but these results represent an important step along the way."


Explore further

CSF test can pick up Alzheimer's early

More information: The article, entitled "Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients with Dementia and/or Parkinsonian Disorders," was published by the Journal of the American Medical Association. archneur.jamanetwork.com/artic … px?articleid=1355364
Citation: Biomarkers in cerebrospinal fluid can identify patients with Alzheimer's disease (2012, October 22) retrieved 18 July 2019 from https://medicalxpress.com/news/2012-10-biomarkers-cerebrospinal-fluid-patients-alzheimer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more